• China Health Group annual report flagged a turnaround push, citing resolved liquidity stress from legacy issues.
• Medical equipment and consumables distribution expanded, supported by a product-mix shift toward higher-turnover items.
• Hospital unit began repositioning toward rehabilitation, nursing care, and health management as policy reforms pressured volumes.
• Fundraising completed via new-share subscriptions and a rights issue, enabling settlement of payables and strengthening cash resources.
• Legal recovery actions continued on loan and interest receivables, including an appeal tied to the Shuangluan Hospital settlement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260731-12263579), on July 31, 2026, and is solely responsible for the information contained therein.